Member Info for xtra

Larry moved 15tonnes of tantalite last year then he should have a good bit left before JORC

Thanks lockedin, great post and your sentiments reflect my own. I would add We cannot totally blame George roach for the environment he is operating in. Mining in Africa is not for the faint hearted and must part of every investors risk calculation - the rewards are immense though for a successful operation since the resources are present in stupid abundancy. certain posters seem to have forgotten this it seems

Hassle the zim government, from what I see they are at least part of the problem. Maybe the biggest part What's the best way to do it?

That vol 2 years ago would have seen this rocket; clearly people are beginning to see the potential here

For the next six months till news breaks

I will get more over the next year - take your time Larry Johnson and be as excited as u want to be - below 5p is a steal for this little tant goldmine

could be good news if the equity settlement is resolved - 9:1 in favour of prem would see it profitable or of course the repayments from zim govt (less likely) I held in prem as it is massively asset rich and has no debt and also has accounts due. Surely great upside and a domino effect of good things very possible since any cash flow can activate other good things

Spot on animal and all our museums cinemas and cars etc. - lot of tantalum needed! Plastic semiconductor will eventually replace but for a decade will be great demand

Internet of things - every little transceiver widget uses tantalum animal

Never thought I'd say it but this could be a hundred bagger £2 a share in 2-3 years but very saddening it's been engineered this low all the same. tantalum prospects are so strong with new IoT trends being considered

Re your comment to Magoo If prem gets he far higher equity stake in RHA then it will become profitable, I think both George roach and zim govt are playing game but keep your chin up lad u seem in a very negative hole on this these days

NO DEBT AND A SHITLOAD OF ASSETS - get in cheap !

BoD must define these very clearly now. This project somehow needs to become a business and new expertise is needed so this stops slipping. Im very respectful of the science but the muddled management and numbskull strategy is a worry.
LTH, first bought in mid-30s but see 7p as worrying rather than a bargain. Not adding more.
Want it to work, potentially massive business but needs much better project management now to stop getting held up by silly strategic and managerial mistakes. Don't post so often, just putting thoughts out there, pls don't expect reply or tit for tat and I'm not being provocative, I post once every three monthsish maximum - just very nonplussed with the typical picture of promising science but clueless management in every other dept

Board must define these very clearly now. This project needs money and new expertise to become a business rather than a cash sinkhole someone else will run off with. I'm very respectful of the wonderful science but the muddled management is a concern - I'm a LTH, first bought in the 30p region a loooong time ago Want it to work - potentially massive business getting held up by silly strategic and management mistakes. Don't post so often just putting it out there my feelings

CF73, climb out of your own arse and grow up mate

So to what drill news was s49 referring

The JORC study pranch the report is a different matter as you well know. I have never seen a JORC to time. I'd be happy if it came in March but I think we all know that is very unlikely with that guy in charge

We had drill news - to what drill news are u referring? I think JORC will be autumn - Larry is so laid back he's horizontal - a JORC is a major undertaking

I had a large holding in this at one point and sold out at 87p due to AN's loan activities at that time for a mortgage and the lax respect of timescales by both the company and the U.S. FDA. In addition a graphene based competing technology looked very strong. I am going to revisit this share soon as it does indeed look good but I'm obviously glad I got out and will reinvest carefully, what I dislike is the unknowns of the FDA - what does anyone think is going on there given the seemingly excellent peer reviewed data and what is the FDA endpoint ? I have my own ideas id just be interested to get views - and as a former investor I'm onside not ramping or trolling. GLA

Best comment on this board in ages funkybeats